Table 3.

Univariate associations with RA-related autoimmunity in the SERA case-control study, 2002–07.

CharacteristicCases, n = 76Controls, n = 154Unadjusted OR*, (95% CI)p
25,OH vitamin D level, mean (SD)26.89 (10.04)25.30 (9.01)1.02 (0.99–1.05)0.22
Age, yrs, mean (SD)42.80 (13.58)41.90 (12.0)1.01 (0.9–1.03)0.52
Race/ethnicity (%)
  Non-Hispanic white64 (84)136 (89)1.00.81
  Hispanic5 (7)8 (5)1.32 (0.39–4.14)
  Black5 (7)8 (5)1.35 (0.42–4.28)
  Other**2 (2)2 (1)2.13 (0.25–18.03)
Sex (%)
  Female52 (68)110 (71)1.00.64
  Male24 (32)44 (29)1.15 (0.65–2.15)
Education (4 declined) (%)
  High school14 (18)25 (17)1.00.94
  College40 (53)82 (55)0.87 (0.41–1.89)
  Graduate22 (29)43 (28)0.91 (0.40–2.12)
Cigarette smoking (%)
  Nonsmoker46 (61)105 (68)1.00.22
  1–19 pack-yrs28 (37)41 (27)1.56 (0.86–2.82)
  20+ pack-yrs2 (3)8 (5)0.57 (0.08–2.39)
Season of blood draw
  Warm months (April–Sep)40 (53)77 (50)1.00.71
  Cold months (Oct–Mar)36 (47)77 (50)0.90 (0.52–1.56)
Body mass index (BMI) category (6 excluded for missing data) (%)
  Normal (18.5–24.9)35 (47)65 (43)1.00.85
  Overweight (25–29.9)25 (19)55 (20)0.85 (0.45–1.60)
  Obese (30+)14 (34)30 (37)0.96 (0.44–2.10)
Taking a supplement containing vitamin D
  Yes56 (74)101 (66)1.00.21
  No20 (26)53 (34)0.68 (0.36–1.24)
Shared epitope (2 excluded for missing data) (%)
  No32 (42)78 (51)1.00.19
  Yes44 (58)74 (49)1.45 (0.83–2.54)
Cohort group (%)
  HLA-DR4-enriched46 (61)94 (61)1.00.94
  First-degree relatives30 (39)60 (39)0.98 (0.56–1.73)
  • * OR calculated using univariate logistic regression;

  • ** included Asian and Native American Indian;

  • OR and 95% CI calculated based on standard deviation difference in 25,OH vitamin D level. Adjusting for age, shared epitope, and smoking status, 25,OH vitamin D levels were not associated with RA-related autoantibodies [adjusted OR 1.23 (95% CI 0.93–1.63) for a 1 standard deviation difference in 25,OH vitamin D, p = 0.15].